Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Nanomedicine Summit 2008

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 11 January 1985:
Vol. 227. no. 4683, pp. 173 - 177
DOI: 10.1126/science.2981428

Articles

Science, Vol 227, Issue 4683, 173-177
Copyright © 1985 by American Association for the Advancement of Science


articles

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

MA Gonda, F Wong-Staal, RC Gallo, JE Clements, O Narayan, and RV Gilden

A study was conducted of the genetic relation between human T-cell lymphotropic retroviruses and visna virus. The human T-cell lymphotropic viruses include those associated with T-cell malignancies (HTLV-I and HTLV-II) as well as the etiologic agent of the acquired immune deficiency syndrome (HTLV-III). Visna virus, a slowly replicating and pathogenic but nononcogenic retrovirus of sheep, is a member of the subfamily Lentivirinae. Results obtained by molecular hybridization and heteroduplex analysis indicated that a greater extent of nucleotide sequence homology exists between HTLV-III and visna virus than between HTLV-III and any of the other viruses. The homology observed under conditions of low stringency spanned the entire genome, but was strongest in the gag/pol region. The morphogenesis and fine structure of HTLV-III and visna virus also demonstrated striking similarities. The data provide strong evidence for a close taxonomic and thus evolutionary relation between HTLV-III and the Lentivirinae subfamily.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HIV Pathogenesis: Knowledge Gained after Two Decades of Research.
J.A. Levy (2006)
Adv. Dent. Res. 19, 10-16
   Abstract »    Full Text »    PDF »
Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies.
A. A. Nabatov, G. Pollakis, T. Linnemann, A. Kliphius, M. I. M. Chalaby, and W. A. Paxton (2004)
J. Virol. 78, 524-530
   Abstract »    Full Text »    PDF »
Identification of a Key Target Sequence To Block Human Immunodeficiency Virus Type 1 Replication within the gag-pol Transframe Domain.
S. Sei, Q.-e. Yang, D. O'Neill, K. Yoshimura, K. Nagashima, and H. Mitsuya (2000)
J. Virol. 74, 4621-4633
   Abstract »    Full Text »
Complete Inhibition of Human Immunodeficiency Virus Gag Myristoylation Is Necessary for Inhibition of Particle Budding.
Y. Morikawa, S. Hinata, H. Tomoda, T. Goto, M. Nakai, C. Aizawa, H. Tanaka, and S. mura (1996)
J. Biol. Chem. 271, 2868-2873
   Abstract »    Full Text »    PDF »
LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.
S Wain-Hobson, J. Vartanian, M Henry, N Chenciner, R Cheynier, S Delassus, L. Martins, M Sala, M. Nugeyre, D Guetard, et al. (1991)
Science 252, 961-965
   Abstract »    PDF »
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
R. Price, B Brew, J Sidtis, M Rosenblum, A. Scheck, and P Cleary (1988)
Science 239, 586-592
   Abstract »    PDF »
The sor gene of HIV-1 is required for efficient virus transmission in vitro.
A. Fisher, B Ensoli, L Ivanoff, M Chamberlain, S Petteway, L Ratner, R. Gallo, and F Wong-Staal (1987)
Science 237, 888-893
   Abstract »    PDF »
Expression and characterization of the trans-activator of HTLV-III/LAV virus.
C. Wright, B. Felber, H Paskalis, and G. Pavlakis (1986)
Science 234, 988-992
   Abstract »    PDF »
The role of mononuclear phagocytes in HTLV-III/LAV infection.
S Gartner, P Markovits, D. Markovitz, M. Kaplan, R. Gallo, and M Popovic (1986)
Science 233, 215-219
   Abstract »    PDF »
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
P. Kanki, F Barin, S M'Boup, J. Allan, J. Romet-Lemonne, R Marlink, M. McLane, T. Lee, B Arbeille, F Denis, et al. (1986)
Science 232, 238-243
   Abstract »    PDF »
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.
T. Lee, J. Coligan, J. Allan, M. McLane, J. Groopman, and M Essex (1986)
Science 231, 1546-1549
   Abstract »    PDF »
Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.
R. Stephens, J. Casey, and N. Rice (1986)
Science 231, 589-594
   Abstract »    PDF »
Genomic diversity of human T-lymphotropic virus type III (HTLV-III).
F Wong-Staal, G. Shaw, B. Hahn, S. Salahuddin, M Popovic, P Markham, R Redfield, and R. Gallo (1985)
Science 229, 759-762
   Abstract »    PDF »
cis- and trans-acting transcriptional regulation of visna virus.
J. Hess, J. Clements, and O Narayan (1985)
Science 229, 482-485
   Abstract »    PDF »
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
J. Allan, J. Coligan, F Barin, M. McLane, J. Sodroski, C. Rosen, W. Haseltine, T. Lee, and M Essex (1985)
Science 228, 1091-1094
   Abstract »    PDF »
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.
W. Robey, B Safai, S Oroszlan, L. Arthur, M. Gonda, R. Gallo, and P. Fischinger (1985)
Science 228, 593-595
   Abstract »    PDF »
Characterization of long terminal repeat sequences of HTLV-III.
B Starcich, L Ratner, S. Josephs, T Okamoto, R. Gallo, and F Wong-Staal (1985)
Science 227, 538-540
   Abstract »    PDF »
More progress on the HTLV family.
J. Marx (1985)
Science 227, 156-157
   PDF »
HTLV-III infection in brains of children and adults with AIDS encephalopathy.
G. Shaw, M. Harper, B. Hahn, L. Epstein, D. Gajdusek, R. Price, B. Navia, C. Petito, C. O'Hara, J. Groopman, et al. (1985)
Science 227, 177-182
   Abstract »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)